Advertisement
UK markets open in 2 hours 24 minutes
  • NIKKEI 225

    37,676.53
    -783.55 (-2.04%)
     
  • HANG SENG

    17,295.93
    +94.66 (+0.55%)
     
  • CRUDE OIL

    82.88
    +0.07 (+0.08%)
     
  • GOLD FUTURES

    2,325.00
    -13.40 (-0.57%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,574.91
    -1,923.36 (-3.60%)
     
  • CMC Crypto 200

    1,385.69
    -38.41 (-2.70%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Is ICU Medical Inc (NASDAQ:ICUI) Expensive For A Reason? A Look At The Intrinsic Value

How far off is ICU Medical Inc (NASDAQ:ICUI) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is fairly priced by projecting its future cash flows and then discounting them to today’s value. I will use the discounted cash flows (DCF) model. It may sound complicated, but actually it is quite simple! Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. Please also note that this article was written in June 2018 so be sure check out the updated calculation by following the link below. Check out our latest analysis for ICU Medical

The calculation

I’m using the 2-stage growth model, which simply means we take in account two stages of company’s growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have perpetual stable growth rate. To begin with we have to get estimates of the next five years of cash flows. For this I used the consensus of the analysts covering the stock, as you can see below. I then discount the sum of these cash flows to arrive at a present value estimate.

5-year cash flow estimate

2018

2019

2020

2021

2022

Levered FCF ($, Millions)

$119.60

$185.40

$223.60

$255.70

$290.50

Source

Analyst x1

Analyst x1

Analyst x1

Analyst x1

Analyst x1

Present Value Discounted @ 8.59%

$110.14

$157.23

$174.62

$183.90

$192.40

Present Value of 5-year Cash Flow (PVCF)= US$818.28m

ADVERTISEMENT

After calculating the present value of future cash flows in the intial 5-year period we need to calculate the Terminal Value, which accounts for all the future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at an annual growth rate equal to the 10-year government bond rate of 2.9%. We discount this to today’s value at a cost of equity of 8.6%.

Terminal Value (TV) = FCF2022 × (1 + g) ÷ (r – g) = US$290.50m × (1 + 2.9%) ÷ (8.6% – 2.9%) = US$5.30b

Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = US$5.30b ÷ ( 1 + 8.6%)5 = US$3.51b

The total value, or equity value, is then the sum of the present value of the cash flows, which in this case is US$4.33b. To get the intrinsic value per share, we divide this by the total number of shares outstanding, or the equivalent number if this is a depositary receipt or ADR. This results in an intrinsic value of $213.27. Relative to the current share price of $301.95, the stock is rather overvalued at the time of writing.

NasdaqGS:ICUI Intrinsic Value June 22nd 18
NasdaqGS:ICUI Intrinsic Value June 22nd 18

Important assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don’t agree with my result, have a go at the calculation yourself and play with the assumptions. Because we are looking at ICU Medical as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighed average cost of capital, WACC) which accounts for debt. In this calculation I’ve used 8.6%, which is based on a levered beta of 0.800. This is derived from the Bottom-Up Beta method based on comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Whilst important, DCF calculation shouldn’t be the only metric you look at when researching a company. What is the reason for the share price to differ from the intrinsic value? For ICUI, there are three key aspects you should look at:

  1. Financial Health: Does ICUI have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Future Earnings: How does ICUI’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of ICUI? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow for every stock on the NASDAQ every 6 hours. If you want to find the calculation for other stocks just search here.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.